Physician profile
James A Breit
NPI 1972582021
$1,964.45
in general payments reported to CMS, 2019-2025
15 companies · $543 in 2025
The $543 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $129 · 2021: $273 · 2022: $232 · 2023: $134 · 2024: $499 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,175.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $791.48 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Memoryshape Breast Implant, Vicryl |
| Abbvie INC. | $448.62 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $156.94 | 2019-2022 | |
| Lumenis, INC | $85.57 | 2021 | |
| Apollo Endosurgery US INC | $83.31 | 2019 | |
| Sientra, INC. | $71.35 | 2021 | |
| Access Pro Medical, LLC | $66.34 | 2025 | Matriderm |
| Davol INC. | $66.33 | 2025 | Arista |
| Galderma Laboratories, L.P. | $66.24 | 2024 | |
| Organogenesis INC. | $39.22 | 2025 | Via Matrix |
| Ethicon US, LLC | $23.48 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $19.83 | 2025 | |
| Medtronic, INC. | $17.33 | 2025 | Minimed 780g |
| Acell, INC. | $14.48 | 2020 | |
| Convatec INC. | $13.93 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Breit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.